Announcements Trials
Browse Landscape

Phase

Phase 1 3

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other solid neoplasm 3

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 3Mesothelioma 3Mesothelioma, Malignant 2Unspecified Adult Solid Tumor 1Thymoma 1Solid Tumor Cancer 1Small Cell Lung Carcinoma 1Seminoma 1Sarcoma, Synovial 1Sarcoma, Ewing 1Sarcoma, Endometrial Stromal 1Rhabdomyosarcoma, Embryonal 1Relapsed Pediatric Solid Tumor 1Primary Myelofibrosis 1Pleural Neoplasms 1Osteosarcoma 1Neurofibrosarcoma 1Multiple Myeloma 1Metastatic Solid Tumors. 1Melanoma 1Mastocytosis 1Malignant mesenchymal tumor 1Liposarcoma 1Leukemia, Mast-Cell 1Leiomyosarcoma 1Hypereosinophilic Syndrome 1Hemangiosarcoma 1Hemangiopericytoma 1Fibroma 1Dermatofibrosarcoma 1

Interventions

Irinotecan 31Paclitaxel 27Gemcitabine 27Cisplatin 25Docetaxel 20Oxaliplatin 16Fluorouracil 15alvocidib 13Leucovorin 13Carboplatin 13Capecitabine 12Bortezomib 10Early Intervention, Educational 9Topotecan 8Taxes 8Bevacizumab 73-aminopyridine-2-carboxaldehyde thiosemicarbazone 7ixabepilone 6Vorinostat 6Temozolomide 6Sorafenib 6Immunohistochemistry 6Immunoenzyme Techniques 67-hydroxystaurosporine 6tanespimycin 5Pharmacogenomic Testing 5Pemetrexed 5Magnetic Resonance Spectroscopy 5Filgrastim 5Etoposide 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unspecified Adult Solid Tumor, Protocol Specific × Imatinib Mesylate × Other solid neoplasm × Clear all
NCT00483366 2024-09-23

Imatinib Mesylate, Gemcitabine, and Capecitabine in Treating Patients With Advanced Solid Tumors

University of Nebraska

Phase 1 Completed
13 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00253565 2013-04-08

Imatinib Mesylate and Capecitabine in Treating Patients With Advanced Solid Tumors

Duke University

Phase 1 Completed
25 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00084513 2010-02-12

Trastuzumab and Imatinib Mesylate in Treating Patients With Recurrent or Metastatic HER2/Neu-Expressing Cancer

Fox Chase Cancer Center

Phase 1 Completed
18 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡